Investigational Site Number-1003 — Nashville, Tennessee

Investigational Site Number-1003 is a clinical research site located in Nashville, Tennessee, United States 37203.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

Investigational Site Number-1003 has participated in 1 clinical trials.

Therapeutic areas: Metastasis.

Sponsors: Synthorx, Inc, a Sanofi company.

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigational Site Number-1003?

Investigational Site Number-1003 has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigational Site Number-1003 conducted?

Investigational Site Number-1003 has 1 clinical trials on record. Their work covers Metastasis.

Is Investigational Site Number-1003 accredited by Crixeo Health?

Investigational Site Number-1003 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigational Site Number-1003?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.